scholarly article | Q13442814 |
P50 | author | Scott A. Guelcher | Q47152305 |
P2093 | author name string | Craig L Duvall | |
Elizabeth J Adolph | |||
Mukesh K Gupta | |||
Christopher E Nelson | |||
Joshua M Shannon | |||
P2860 | cites work | Antibody-mediated targeting of siRNA via the human insulin receptor using avidin-biotin technology | Q39903849 |
Intracellular delivery of a proapoptotic peptide via conjugation to a RAFT synthesized endosomolytic polymer | Q39908819 | ||
Injectable biodegradable polyurethane scaffolds with release of platelet-derived growth factor for tissue repair and regeneration | Q39976454 | ||
Enhancing polysaccharide-mediated delivery of nucleic acids through functionalization with secondary and tertiary amines | Q39994489 | ||
Efficient in vivo delivery of siRNA to the liver by conjugation of alpha-tocopherol | Q39999051 | ||
Synthesis and in vitro biocompatibility of injectable polyurethane foam scaffolds | Q40268506 | ||
Poly(2-alkylacrylic acid) polymers deliver molecules to the cytosol by pH-sensitive disruption of endosomal vesicles. | Q40605445 | ||
A biomimetic pH-responsive polymer directs endosomal release and intracellular delivery of an endocytosed antibody complex | Q40703521 | ||
Quantum dot-amphipol nanocomplex for intracellular delivery and real-time imaging of siRNA. | Q42138120 | ||
Cellular uptake of cationic polymer-DNA complexes via caveolae plays a pivotal role in gene transfection in COS-7 cells | Q42582978 | ||
Nanofiber-mediated controlled release of siRNA complexes for long term gene-silencing applications. | Q42810537 | ||
Synthesis, in vitro degradation, and mechanical properties of two-component poly(ester urethane)urea scaffolds: effects of water and polyol composition | Q42826187 | ||
Snail1 down-regulation using small interfering RNA complexes delivered through collagen scaffolds | Q42832165 | ||
RNAi-based treatment for neovascular age-related macular degeneration by Sirna-027. | Q42977647 | ||
Sustained release of vancomycin from polyurethane scaffolds inhibits infection of bone wounds in a rat femoral segmental defect model | Q43103895 | ||
In vivo siRNA delivery with dendritic poly(L-lysine) for the treatment of hypercholesterolemia | Q43262834 | ||
The effects of rhBMP-2 released from biodegradable polyurethane/microsphere composite scaffolds on new bone formation in rat femora | Q44979449 | ||
Rational design of composition and activity correlations for pH-sensitive and glutathione-reactive polymer therapeutics | Q45180639 | ||
Inhibition of Smad3 expression in radiation-induced fibrosis using a novel method for topical transcutaneous gene therapy | Q45862302 | ||
The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. | Q45977543 | ||
On the use of the Weibull function for the discernment of drug release mechanisms | Q46866690 | ||
DNA, RNA and hybrid RNA-DNA oligomers of identical sequence: structural and dynamic differences. | Q52073402 | ||
Localized, targeted, and sustained siRNA delivery | Q83460693 | ||
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans | Q27860867 | ||
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles | Q29615957 | ||
Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery | Q33440795 | ||
Functional delivery of siRNA in mice using dendriworms | Q33686651 | ||
pH-Responsive Polymeric Micelle Carriers for siRNA Drugs | Q33708003 | ||
First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder. | Q33730680 | ||
Membrane solubilization by a hydrophobic polyelectrolyte: surface activity and membrane binding | Q34018523 | ||
In vivo activity of nuclease-resistant siRNAs | Q34365687 | ||
Development of a novel endosomolytic diblock copolymer for siRNA delivery | Q35031634 | ||
Hyaluronic acid and fibrin hydrogels with concentrated DNA/PEI polyplexes for local gene delivery | Q35112949 | ||
Improved diabetic wound healing through topical silencing of p53 is associated with augmented vasculogenic mediators | Q35133453 | ||
Polycation gene delivery systems: escape from endosomes to cytosol | Q35169492 | ||
Controlled release of IGF-1 and HGF from a biodegradable polyurethane scaffold | Q35432628 | ||
Injectable polyurethane composite scaffolds delay wound contraction and support cellular infiltration and remodeling in rat excisional wounds | Q35783657 | ||
Intracellular trafficking of nonviral vectors | Q36218205 | ||
The silent treatment: siRNAs as small molecule drugs | Q36362370 | ||
Nonviral delivery of synthetic siRNAs in vivo | Q37024768 | ||
Biodegradable polyurethanes: synthesis and applications in regenerative medicine | Q37153739 | ||
The effect of the local delivery of platelet-derived growth factor from reactive two-component polyurethane scaffolds on the healing in rat skin excisional wounds | Q37195004 | ||
Barriers to successful delivery of short interfering RNA after systemic administration | Q37195296 | ||
Biodegradable elastomeric scaffolds with basic fibroblast growth factor release | Q37233486 | ||
Antisense makes sense in engineered regenerative medicine | Q37328072 | ||
Nonviral methods for siRNA delivery | Q37360226 | ||
Lipidic systems for in vivo siRNA delivery | Q37598096 | ||
Bioapplications of RAFT polymerization | Q37599838 | ||
Peptide mediated siRNA delivery | Q37622416 | ||
Higuchi equation: derivation, applications, use and misuse. | Q37860531 | ||
siRNA Knockdown of Ribonucleotide Reductase Inhibits Melanoma Cell Line Proliferation Alone or Synergistically with Temozolomide | Q39644504 | ||
Characterization of the degradation mechanisms of lysine-derived aliphatic poly(ester urethane) scaffolds | Q39652239 | ||
Localized and sustained delivery of silencing RNA from macroscopic biopolymer hydrogels. | Q39837392 | ||
P433 | issue | 4 | |
P1104 | number of pages | 8 | |
P304 | page(s) | 1154-1161 | |
P577 | publication date | 2011-11-05 | |
P1433 | published in | Biomaterials | Q15751139 |
P1476 | title | Sustained local delivery of siRNA from an injectable scaffold | |
P478 | volume | 33 |
Q47294434 | A low-molecular-weight supramolecular hydrogel of riboflavin bolaamphiphile for VEGF-siRNA delivery |
Q38827304 | Advances and perspectives in tooth tissue engineering. |
Q35682248 | Chitosan/siCkip-1 biofunctionalized titanium implant for improved osseointegration in the osteoporotic condition |
Q42408555 | Conjugation of palmitic acid improves potency and longevity of siRNA delivered via endosomolytic polymer nanoparticles. |
Q36408468 | Controlling mesenchymal stem cell gene expression using polymer-mediated delivery of siRNA |
Q38105523 | Design and development of reactive injectable and settable polymeric biomaterials |
Q39038930 | Engineered Hydrogels for Local and Sustained Delivery of RNA-Interference Therapies. |
Q36765566 | Ex vivo red blood cell hemolysis assay for the evaluation of pH-responsive endosomolytic agents for cytosolic delivery of biomacromolecular drugs. |
Q33831440 | Hybrid lipid-polymer nanoparticles for sustained siRNA delivery and gene silencing |
Q38967041 | Hydrogel doped with nanoparticles for local sustained release of siRNA in breast cancer |
Q38152745 | Injectable foams for regenerative medicine |
Q40568687 | Injected biodegradable polyurethane scaffolds support tissue infiltration and delay wound contraction in a porcine excisional model |
Q42856140 | Local Delivery of PHD2 siRNA from ROS-Degradable Scaffolds to Promote Diabetic Wound Healing |
Q41240553 | Macrophage-specific RNA interference targeting via "click", mannosylated polymeric micelles |
Q42077942 | Matrix Metalloproteinase Responsive, Proximity-activated Polymeric Nanoparticles for siRNA Delivery. |
Q35799937 | MiRNA inhibition in tissue engineering and regenerative medicine |
Q36506217 | MicroRNAs in vascular tissue engineering and post-ischemic neovascularization |
Q39152253 | Nanolayered siRNA dressing for sustained localized knockdown |
Q36585532 | Photocleavable Hydrogels for Light-Triggered siRNA Release. |
Q57171043 | Poly(ester-urethane) scaffolds: effect of structure on properties and osteogenic activity of stem cells |
Q42816439 | Self-Assembled Wound Dressings Silence MMP-9 and Improve Diabetic Wound Healing In Vivo |
Q35527863 | Spatial control of cell gene expression by siRNA gradients in biodegradable hydrogels |
Q34147775 | Sustained localized presentation of RNA interfering molecules from in situ forming hydrogels to guide stem cell osteogenic differentiation |
Q28087657 | Technologies for controlled, local delivery of siRNA |
Q37633993 | Tunable delivery of siRNA from a biodegradable scaffold to promote angiogenesis in vivo. |
Q33816969 | Tuning PEGylation of mixed micelles to overcome intracellular and systemic siRNA delivery barriers. |
Q36382827 | Zwitterionic Nanocarrier Surface Chemistry Improves siRNA Tumor Delivery and Silencing Activity Relative to Polyethylene Glycol. |
Q27026234 | siRNA Delivery from an Injectable Scaffold for Wound Therapy |
Search more.